Fund moves

Danaher Corporation (DHR): Soros Fund Management reduced its stake -90K shares

Soros Fund Management reduced its stake in Danaher Corporation, per its Q1 2025 13F.

40K
Shares reported · -90K vs prior quarter
0.16%
Disclosed portfolio weight
$8.2M
Reported value
Holdings as of
Mar 31, 2025
Filed
May 15, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 8, 2015CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
  2. Oct 29, 2024CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  3. Feb 25, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  4. Mar 4, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  5. Mar 27, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  6. Apr 7, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  7. Apr 8, 2025CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
  8. Apr 11, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  9. Apr 21, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  10. Apr 30, 2025Insider · 1 personInsiders: 2 sales (~$3.1M)
  11. May 12, 2025Insider · 1 personInsiders: 8 sales (~$245.9M)
  12. May 12, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  13. May 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000

What came next

  1. Jun 11, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  2. Jun 12, 2025CongressDisclosed sale of DHR — reported range $50,001 - $100,000
  3. Jul 22, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  4. Jul 24, 2025FDARecall: MicroScan Neg MIC 56 REF C42464 UDI-DI code: 15099590731212 MicroScan panels are designed for use in determining antimicrobial agent susceptibility and/or iden…
  5. Aug 1, 2025FDAFDA device clearance: Access hsTnI
  6. Aug 4, 2025FDARecall: DxC 500 AU Module w/ISE, DxC 500i, With ISE, REF: C63522 and DxC 500 AU Module, DxC 500i, Without ISE, REF: C6352; part of the DxC 500i Clinical Analyzer
  7. Aug 6, 2025FDARecall: Xpert SA Nasal Complete Catalog Number: GXSACOMP-10 UDI-DI code: 07332940000158 Xpert SA Nasal Complete kit; 10 test kit: A collection of reagents and other as…
  8. Aug 13, 2025FDARecall: UniCel DxH 800 COULTER Cellular Analysis System, configured with the Led HGB Photometer REFs:B24802, 629029, B63322
  9. Aug 13, 2025FDARecall: UniCel DxH 900 COULTER Cellular Analysis System, configured with the Led HGB Photometer REF: C11478
  10. Aug 13, 2025FDARecall: UniCel DxH 690T COULTER Cellular Analysis System, configured with the Led HGB Photometer REF: C34520
  11. Aug 13, 2025FDARecall: UniCel DxH 600 COULTER Cellular Analysis System, configured with the Led HGB Photometer REF:B23858
  12. Aug 15, 2025FDAFDA device clearance: MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)
  13. Aug 20, 2025FDAFDA device clearance: MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan)
  14. Aug 22, 2025InsiderDirector sold ~$586K of DHR shares in the open market
  15. Aug 28, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  16. Sep 3, 2025FDARecall: SYNCHRON Systems Phosphorus (PHOSm) Reagent REF: 467868 For In Vitro Diagnostic Use, Rx Only.
  17. Sep 8, 2025FDARecall: CellMek SPS Sample Preparation System, REF: C44603. Software versions 2.2.122.0 and prior, and Instructions for Use (IFU) revisions AD and prior. These CellMek…
  18. Sep 8, 2025FDARecall: MicroScan Neg Multidrug Resistant MIC 1 REF C32368 UDI-DI code: 15099590720568 Intended Use- For use with MicroScan Dried Gram Negative MIC/Combo Panels and Dr…
  19. Sep 9, 2025Company filing · Form 8-K · Bylaws or charter, Other newsChanged its bylaws, charter or fiscal year, and reported other company news
  20. Sep 9, 2025FDAFDA device clearance: Access anti-HAV
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

How this filing works

Explore the data

Common questions

What does this filing report about Danaher Corporation (DHR) stock?

Soros Fund Management reduced its stake in Danaher Corporation, per its Q1 2025 13F. Now 40K shares, $8.2M reported value, 0.16% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2025. Filed: May 15, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Danaher Corporation recently?

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days. They are listed on the DHR page.

Does this mean DHR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data